Implication of species change of Nontuberculous Mycobacteria during or after treatment
- PMID: 29262802
- PMCID: PMC5738815
- DOI: 10.1186/s12890-017-0539-7
Implication of species change of Nontuberculous Mycobacteria during or after treatment
Abstract
Background: Co-existence or subsequent isolation of multiple nontuberculous mycobacteria (NTM) species in same patient has been reported. However, clinical significance of these observations is unclear. The aim of this study was to determine clinical implications of changes of NTM species during or after treatment in patients with NTM lung disease.
Methods: Patients with NTM lung disease, who experienced changes of NTM species during treatment or within 2 years of treatment completion between January 1, 2009 and December 31, 2015, were included in the analysis. Demographic, clinical, microbiological, and radiographic data were reviewed and analyzed.
Results: During the study period, 473 patients were newly diagnosed with NTM lung disease. Treatment was started in 164 patients (34.6%). Among these 164 patients, 16 experienced changes of NTM species during or within 2 years of treatment completion. Seven showed changes from M. avium complex (MAC) to M. abscessus subspecies abscessus (MAA) and five patients displayed changes from M. abscessus subspecies massiliense (MAM) to MAC. With isolation of new NTM species, 6 out of 7 patients with change from MAC to MAA reported worsening of symptoms, whereas none of the five patients with change from MAM to MAC reported worsening of symptoms. All MAA isolated during or after treatment for MAC lung diseases showed inducible resistance to clarithromycin.
Conclusions: Change of NTM species may occur during or after treatment for NTM lung disease. Especially, changes from MAC to MAA is accompanied by symptomatic and radiographic worsening as well as inducible resistance to clarithromycin.
Keywords: Clarithromcycin resistance; Mycobacterium abscessus subspecies abscessus; Mycobacterium avium Complex; Nontuberculous mycobacteria species change.
Conflict of interest statement
Ethics approval and consent to participate
The study protocol was approved by the Institutional Review Board of Seoul National University Hospital (IRB No: 1608-046-784) and was conducted in accordance with the amended Declaration of Helsinki. All participants provided written informed consent before enrollment.
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures

Similar articles
-
Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.Antimicrob Agents Chemother. 2018 Sep 24;62(10):e01105-18. doi: 10.1128/AAC.01105-18. Print 2018 Oct. Antimicrob Agents Chemother. 2018. PMID: 30104265 Free PMC article.
-
Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.PLoS One. 2015 Jan 12;10(1):e0116236. doi: 10.1371/journal.pone.0116236. eCollection 2015. PLoS One. 2015. PMID: 25581038 Free PMC article.
-
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense.Clin Infect Dis. 2017 Feb 1;64(3):301-308. doi: 10.1093/cid/ciw723. Epub 2016 Nov 10. Clin Infect Dis. 2017. PMID: 28011609
-
The treatment of rapidly growing mycobacterial infections.Clin Chest Med. 2015 Mar;36(1):67-78. doi: 10.1016/j.ccm.2014.10.004. Epub 2014 Nov 5. Clin Chest Med. 2015. PMID: 25676520 Review.
-
Antibiotic treatment for nontuberculous mycobacterial lung disease.Expert Rev Respir Med. 2016;10(5):557-68. doi: 10.1586/17476348.2016.1165611. Epub 2016 Mar 30. Expert Rev Respir Med. 2016. PMID: 26967761 Review.
Cited by
-
Clinical and microbiological characteristics of non-tuberculous mycobacteria diseases in Singapore with a focus on pulmonary disease, 2012-2016.BMC Infect Dis. 2019 May 17;19(1):436. doi: 10.1186/s12879-019-3909-3. BMC Infect Dis. 2019. PMID: 31101082 Free PMC article.
-
Identification and Characteristics of Co-isolation of Multiple Nontuberculous Mycobacteria.Intern Med. 2021 Oct 15;60(20):3213-3219. doi: 10.2169/internalmedicine.5300-20. Epub 2021 Apr 26. Intern Med. 2021. PMID: 33896860 Free PMC article.
-
Biochip-Based Identification of Mycobacterial Species in Russia.Int J Mol Sci. 2024 Dec 8;25(23):13200. doi: 10.3390/ijms252313200. Int J Mol Sci. 2024. PMID: 39684910 Free PMC article.
-
Screening and Drug Resistance Analysis of Non-Tuberculous Mycobacteria in Patients with Suspected Pulmonary Tuberculosis on the Hainan Island, China.Infect Drug Resist. 2023 Jan 25;16:463-476. doi: 10.2147/IDR.S396050. eCollection 2023. Infect Drug Resist. 2023. PMID: 36721630 Free PMC article.
-
Mixed nontuberculous mycobacteria in an immunocompromised patient with probable progressive multifocal leukoencephalopathy.IJID Reg. 2024 Nov 29;14:100502. doi: 10.1016/j.ijregi.2024.100502. eCollection 2025 Mar. IJID Reg. 2024. PMID: 39810748 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical